Core Laboratories Inc (CLB) valuation
Core Laboratories P/E ratio history
Core Laboratories trades at 31.3 times its earnings over the last twelve months and 16.5 times the earnings analysts expect over the next twelve. At its last 9 fiscal year ends its P/E ranged from 16.5 (year to Dec 2019) to 82.2 (year to Dec 2016), with a median of 33.3.
| Fiscal year ended | Price | EPS | P/E | Forward P/E |
|---|---|---|---|---|
| Dec 31, 2025 | $16.03 | $0.63 | 25.4 | 20.4 |
| Dec 31, 2024 | $17.31 | $0.66 | 26.2 | 17.4 |
| Dec 31, 2023 | $17.66 | $0.77 | 22.9 | 17.3 |
| Dec 31, 2022 | $20.27 | $0.42 | 48.3 | — |
| Dec 31, 2021 | $22.31 | $0.44 | 50.7 | — |
| Dec 31, 2020 | $26.51 | -$2.20 | n/m | — |
| Dec 31, 2019 | $37.67 | $2.28 | 16.5 | — |
| Dec 31, 2018 | $59.66 | $1.79 | 33.3 | — |
| Dec 31, 2017 | $109.55 | $1.88 | 58.3 | — |
| Dec 31, 2016 | $120.04 | $1.46 | 82.2 | — |
n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.
Core Laboratories valuation against its peers
| Company | Market value | P/E | Forward P/E | Price / sales |
|---|---|---|---|---|
| Core LaboratoriesCLB | $490M | 31.3 | 16.5 | 0.9 |
| Sandridge EnergySD | $531M | 6.4 | 7.9 | 3.0 |
| Summit MidstreamSMC | $428M | — | — | 0.7 |
| Sable OffshoreSOC | $424M | — | — | 3.1 |
| Oil States InternationalOIS | $578M | — | 16.1 | 0.9 |
| Natural Gas Services GroupNGS | $408M | 20.1 | 14.4 | 2.1 |
| W And T OffshoreWTI | $603M | — | — | 1.1 |
| Primeenergy ResourcesPNRG | $369M | 22.0 | 22.8 | 2.1 |
| Vaalco EnergyEGY | $671M | — | — | 1.9 |
| Peer median | 20.1 | 15.3 | 2.0 |
Reading these multiples
The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.
See also: CLB financials · CLB returns
No forecast, no recommendation. This page describes Core Laboratories Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.